Max Planck Institute for Molecular Biomedicine
The Max Planck Institute for Molecular Biomedicine was founded on 1 April 2001 in Münster, North Rhine-Westphalia, Germany. It is part of the Max Planck Society. The current managing director is Prof. Sara Wickström. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Max Planck Institute for Molecular Biomedicine, Germany, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
76%
Total
Publications
1.4K
Total Open
Publications
1K
Total
Citations
89K
Open Access
Percentage
76%
Total
Publications
1.4K
Total Open
Publications
1K
Total
Citations
89K
Breakdown
Publisher Open
19%
Both
46%
Other Platform Open
11%
Closed
24%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
333
Hybrid 35%
313
No Guarantees 28%
244
Other Platform Open
Domain 82%
639
Institution 31%
240
Preprint 16%
124
Other Internet 12%
91
Public 11%
87
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 638 |
Europe PMC | Domain | 384 |
bioRxiv | Preprint | 103 |
Semantic Scholar | Public | 74 |
DOI | Other Internet | 48 |
German National Library - URN:NBN Resolver for Germany & Switzerland | Institution | 22 |
Research Square | Preprint | 18 |
Max Planck Society - MPG.PuRe | Institution | 16 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 15 |
University of Bern - Bern Open Repository and Information System | Institution | 15 |